AU2021343539A1 - Sik inhibitors and methods of use thereof - Google Patents
Sik inhibitors and methods of use thereof Download PDFInfo
- Publication number
- AU2021343539A1 AU2021343539A1 AU2021343539A AU2021343539A AU2021343539A1 AU 2021343539 A1 AU2021343539 A1 AU 2021343539A1 AU 2021343539 A AU2021343539 A AU 2021343539A AU 2021343539 A AU2021343539 A AU 2021343539A AU 2021343539 A1 AU2021343539 A1 AU 2021343539A1
- Authority
- AU
- Australia
- Prior art keywords
- substituted
- compound
- unsubstituted
- ring
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063081089P | 2020-09-21 | 2020-09-21 | |
| US63/081,089 | 2020-09-21 | ||
| PCT/US2021/051375 WO2022061312A1 (en) | 2020-09-21 | 2021-09-21 | Sik inhibitors and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2021343539A1 true AU2021343539A1 (en) | 2023-05-18 |
| AU2021343539A9 AU2021343539A9 (en) | 2024-09-26 |
Family
ID=80775691
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2021343539A Pending AU2021343539A1 (en) | 2020-09-21 | 2021-09-21 | Sik inhibitors and methods of use thereof |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230265099A1 (https=) |
| EP (1) | EP4213851A4 (https=) |
| JP (1) | JP2023544446A (https=) |
| CN (1) | CN117136061A (https=) |
| AU (1) | AU2021343539A1 (https=) |
| CA (1) | CA3193194A1 (https=) |
| WO (1) | WO2022061312A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4526307A1 (en) * | 2022-05-17 | 2025-03-26 | Soltego, Inc. | Pyrimidopyrimidone compounds and methods of use thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104418860B (zh) * | 2013-08-20 | 2016-09-07 | 中国科学院广州生物医药与健康研究院 | 嘧啶并杂环类化合物及其药用组合物和应用 |
| WO2018009544A1 (en) * | 2016-07-05 | 2018-01-11 | The Broad Institute, Inc. | Bicyclic urea kinase inhibitors and uses thereof |
| US11241435B2 (en) * | 2016-09-16 | 2022-02-08 | The General Hospital Corporation | Uses of salt-inducible kinase (SIK) inhibitors for treating osteoporosis |
| AU2018226771B2 (en) * | 2017-02-28 | 2023-11-23 | Dana-Farber Cancer Institute, Inc. | Uses of pyrimidopyrimidinones as SIK inhibitors |
| CA3124574A1 (en) * | 2018-12-28 | 2020-07-02 | Spv Therapeutics Inc. | Cyclin-dependent kinase inhibitors |
| AU2021262482A1 (en) * | 2020-04-28 | 2023-01-05 | Iomx Therapeutics Ag | Bicyclic kinase inhibitors and uses thereof |
-
2021
- 2021-09-21 US US18/027,556 patent/US20230265099A1/en active Pending
- 2021-09-21 JP JP2023542830A patent/JP2023544446A/ja active Pending
- 2021-09-21 WO PCT/US2021/051375 patent/WO2022061312A1/en not_active Ceased
- 2021-09-21 CA CA3193194A patent/CA3193194A1/en active Pending
- 2021-09-21 CN CN202180078421.4A patent/CN117136061A/zh active Pending
- 2021-09-21 EP EP21870430.2A patent/EP4213851A4/en active Pending
- 2021-09-21 AU AU2021343539A patent/AU2021343539A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2022061312A1 (en) | 2022-03-24 |
| EP4213851A4 (en) | 2025-08-06 |
| CN117136061A (zh) | 2023-11-28 |
| AU2021343539A9 (en) | 2024-09-26 |
| US20230265099A1 (en) | 2023-08-24 |
| EP4213851A1 (en) | 2023-07-26 |
| JP2023544446A (ja) | 2023-10-23 |
| CA3193194A1 (en) | 2022-03-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11639337B2 (en) | Bicyclic heteroaryl derivatives and preparation and uses thereof | |
| AU2018226771B2 (en) | Uses of pyrimidopyrimidinones as SIK inhibitors | |
| KR101839915B1 (ko) | 아릴아미노 퓨린 유도체, 그의 제조 방법 및 약학적 용도 | |
| ES2978930T3 (es) | Moduladores de los receptores de arilo y procedimientos de fabricación y utilización de los mismos | |
| JP7050093B2 (ja) | 置換５員および６員複素環式化合物、その調製方法、薬剤の組み合わせおよびその使用 | |
| US20170145011A1 (en) | Pyrrolopyrazine-Spirocyclic piperidine amides as modulators of ion channels | |
| TW201429957A (zh) | 用於激酶調節及其適應症之化合物及方法 | |
| ES3057371T3 (en) | Antagonists of the muscarinic acetylcholine receptor m4 | |
| JP7826325B2 (ja) | Ｂｃｒ－ａｂｌチロシンキナーゼの阻害のための７－アザインドール化合物 | |
| CN109476672A (zh) | 新型杂环衍生物化合物及其用途 | |
| WO2018209239A1 (en) | Potent agelastatin derivatives as modulators for cancer invasion and metastasis | |
| US20150031682A1 (en) | Anti-malarial agents | |
| KR102369925B1 (ko) | 구조적으로 제한된 PI3K 및 mTOR 억제제 | |
| AU2021343539A9 (en) | Sik inhibitors and methods of use thereof | |
| KR20240019078A (ko) | 포도막 흑색종을 치료하기 위한 우레아 유도체 | |
| CA3087926A1 (en) | Cycloalkyl substituted pyrazolopyrimidines having activity against rsv | |
| CN102070555A (zh) | 3-(2-氨基-乙基)-5-(3-环己基-亚丙基)-噻唑啉-2，4-二酮及其衍生物 | |
| CN114163433A (zh) | 一种小檗碱衍生物及其制备方法和应用 | |
| CN110730782B (zh) | 光动力治疗化合物和光动力治疗方法 | |
| CN115109058B (zh) | 一种用于治疗胃癌的药物及其制备方法 | |
| US20250250265A1 (en) | Benzothiazole-phenylsulfonyl-piperidine analogs as activators of nacylphosphatidylethanolamine hydrolyzing phospholipase d | |
| KR20200090767A (ko) | 피부 장애의 치료 | |
| RS55998B1 (sr) | Novi anti-malarijski agensi | |
| CA3103160C (en) | Pyridopyrimidinone derivatives for use as axl inhibitors | |
| US20230134760A1 (en) | Car and nrf2 dual activator agents for cyclophosphamide-based and doxorubicin-based treatments of cancer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| SREP | Specification republished |